Total Funding
51
41
Total FundingGrant raised
Growth Score
-10 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
89053
KayoThera develops therapeutics used to cure late-stage and metastatic cancers.
- Mark Esposito: Founder & VPPast Role: KayoThera, Founder & CEO
About the Company
KayoThera is a biotechnology company developing therapeutics used to cure late-stage and metastatic cancers. Its programs work on inhibiting a key enzyme that is responsible for protecting the cancer cells and depleting regulatory T-cells that intends to cure hitherto incurable cancers and give hope to patients. The company's mission is to
develop the first-in-class immuno- and targeted therapies to drive cures in advanced cancers
KayoThera was founded in 2019 and is headquartered in Princeton, New Jersey.
